This book provides a list of concise extemporaneous ophthalmic preparations and standardizes the formulation of the products by suggesting specific strength, route of administration, appropriate vehicle, and method of preparation. Pharmaceutical industries have greatly expanded their share of ophthalmic drugs in recent years. However, physicians and pharmacists are frequently called to prepare sterile products intended for ophthalmic use due to lack of availability of licensed drugs in the market. This book contains the most appropriate formulation of each medication based on published and documented stability data. 

Extemporaneous Ophthalmic Preparations, 2nd Edition has been fully revised featuring new ophthalmic preparations for Intracameral epinephrine, Intracameral lidocaine and Losartan eye drops to name a few. This book is a unique and valuable companion for many physicians and pharmacy practitioners who are frequently engaged in the compounding of sterile ophthalmic preparation.

Eman A. Alghamdi is a Senior Drug Safety Expert and clinical pharmacist with over 15 years of experience in pharmacovigilance, pharmacoepidemiology, hospital pharmacy, and regulatory science. Her early work in tertiary care involved sterile and nonsterile compounding, formulary management, drug information, and ophthalmology support. She developed guidelines for extemporaneous ophthalmic preparations, addressing stability and safety challenges. At the Saudi Food and Drug Authority, she leads national and international initiatives in drug safety, real‑world evidence, and risk–benefit assessment, and is an active researcher recognized through awards and professional leadership roles.

Abdulmalik Y. Alqahtani is a consultant ophthalmologist specializing in anterior segment surgery with more than 20 years of clinical experience in cornea, cataract, and refractive procedures. He practices at Prince Sultan Military Medical City in Riyadh and has served as Head of Ophthalmology and Head of the Anterior Segment Division in major tertiary centers. He completed his fellowship at King Khaled Eye Specialist Hospital and holds advanced degrees in public policy and health economics from the University of Chicago and the London School of Economics. He has authored peer‑reviewed research and is active in national and international ophthalmology conferences.

Mazen M. Sinjab is a senior ophthalmic surgeon, professor, and head of the Ophthalmology Department at Dr Sulaiman Al Habib Hospital in Dubai. A fellow and examiner of the Royal College of Ophthalmologists and the Royal College of Surgeons of Edinburgh, he specializes in cataract, refractive surgery, and keratoconus, with expertise in tomography, wavefront, and biometry. He is a leading educator, delivering thousands of lectures and founding Sinjab Academy, a global platform with over 14,000 members. His scientific influence has earned numerous international honors. He also serves as founder and secretary‑general of the International Keratoconus Society and sits on multiple examination boards.

Khalid M. Alyahya is a consultant clinical pharmacist at Prince Sultan Military Medical City in Riyadh, specializing in internal medicine with a focus on endocrine and diabetes care. He earned his PhD in clinical pharmacy from Cardiff University and has served as a certified specialist and consultant pharmacist. He previously directed the Drug and Poisoning Information Center and chairs key committees in formulary management, patient education, and accreditation readiness. A major contributor to pharmacy education, he leads residency programs, teaches at several universities, and has supervised numerous research projects. He also serves on national advisory committees in bioethics, research, and pharmacy practice.